Valdivieso R, Pola J, Losada E, Subiza J, Armentia A, Zapata C
Department of Allergy, Hospital Ramon y Cajal, Madrid, Spain.
Allergy. 1988 Jan;43(1):71-3. doi: 10.1111/j.1398-9995.1988.tb02046.x.
We present the case of a 58-year-old non-atopic woman who suffered an adverse reaction to orally administered nalidixic acid, which had been prescribed for the treatment of a urinary tract infection. The single-blind oral provocation test was positive; the patient presented the clinical features of an anaphylactoid reaction 3 min after administration of nalidixic acid. Both the skin test and the histamine release test were negative. These results suggest that we are dealing with an anaphylactoid reaction not described before with this drug.
我们报告一例58岁非特应性女性病例,该患者口服萘啶酸(该药用于治疗尿路感染)后出现不良反应。单盲口服激发试验呈阳性;患者在服用萘啶酸3分钟后出现类过敏反应的临床特征。皮肤试验和组胺释放试验均为阴性。这些结果表明,我们正在处理一种此前未报道过的与该药物相关的类过敏反应。